GALIBRA NEUROSCIENCE, INC.
CHESTNUT HILL, MA · Founded 2023 · CIK 0002008971 · Biotech · Private
AAV gene therapy for succinic semialdehyde dehydrogenase deficiency using blood-brain-barrier penetrable viral vectors
galibraneuroscience.com →- Grants
- $500K
- 1 award
- Sector median: 1
- Raised
- $100K
- 1 Form D · Jan 2024
- 32 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $100,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing Brain Penetrable AAV Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) | $500,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2655 | RESTORE THERAPEUTICS LLC | — | — |
| 2656 | nVector, Inc. | — | $125K |
| 2657 | Sustained Therapeutics Inc. | — | $100K |
| 2658 | GALIBRA NEUROSCIENCE, INC. | — | $100K |
| 2659 | Blue Marlin Therapeutics, Inc. | — | $100K |
| 2660 | CINDER BIOLOGICAL, INC. | — | $100K |
| 2661 | Nano Pharmasolutions Inc. | — | $75K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Hing Cheong LeeDirector · Executive Officer
- Alexander RotenbergDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.